Mechanisms controlling Self-renewal and pluripotency in human embryonic stem cells

Biotechnology and Genetic Engineering Reviews

Volumn 23, Issue 1, 2006, Pages 273-290

  Inniss, Katie ^a   Avery, Stuart ^a   Moore, Harry ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EMBRYONIC STEM CELLS; PLURIPOTENCY; SELF RENEWAL;

STEM CELLS;

EID: 81755181874     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2006.10648088     Document Type: Article

References (104)

1. AWIT M., SHARIKI. C., MARGULETS. V. and ITSKovITZ-ELDOR, J. (2004). Feeder layer and serum-free culture of human embryonic stem cells. Biology of Reproduction70, 837–845
2. Anneren. N, C., COWAN. C.A. and MELTON. D.A. (2004).The Src family of tyrosine kinases is important for embryonicsten-stem cell self-renewal. Journal of Biological Chemistry279, 31590–31598
3. Aubert. J., DUNSTAN. H., CHAMBERS. I. and SMITH. A. (2002). Functional gene screening in embryonic stern cells implicates WNT antagonism in neural differentiation. Nature Biowlmology20, l240-l245
4. Austin. T.W., SOLAR, G.P., ZIEGLER. F.C., LIEM, L. and MATTHEWS. W. (1997). A role for the WNT gene family in haematopoicsis:expansion of multilineage progenitor cells. Blood89, 3624–3635
5. Barnea. E. and BERGMAN. Y. (2000). Synergy of SF1 and RAR in activation of Oct-3/4 promoter. Journal of Biological Chemistry275, 6608–6619
6. Beattie. G.M., LOPEZ. A.D., BUCAY, N. et al. (2005). Activin A maintains pluripotency of human embryonic sterm cells in the absence of feeder layers. StemCells23, 489–495
7. BEN-SHUSHAN, E., SHARIR. H., PIKARSKY. E. and BERGMAN. Y. (1995). A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TH, and retinoic acid receptor:retinoid X receptor heterodiniers regulates Oct-3/4 expression in embryonal carcinomacells. Molecular and Cellular Biology15, 1034–1048
8. Besser. D. (2004). Expression of nodal. lefty-a, and lefty-B in undifferentiated humanembryonic stern cells requires activation of Smad2/3. Journal of Biological Chemistry279, 45076–45084
9. Bhattacharya. B., MIURA. T., BRANDENBERGER. R. et al. (2004). Gene expression in human embryonicstem cell lines:unique molecular signature. Blood103,2956–2964
10. Boyer. L.A., LEE. T.I., COLE. M.F. et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell122, 947–956
11. Brandenberger. R., WEI. H., ZHANG. S. et al. (2004). Transcriptome characterization elucidates signalling networks that control human ES cell growth and differentiation. Nature Biotechiudogy22, 707–716
12. Brook. F.A. and GARDNER. R.L. (1997). The origin and efficient derivation of embryonic stem cells in the mouse. Proceedings of the National Academy of Sciences of the United States of America 94, 5709–5712
13. Burdon. T., STRACEY. C., CHAMBERS. I., NICHOLS, J. and SMITH, A. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Developmental Biology210, 30–43
14. Cadigan. K.M. and NUSSEL R. (1997). WNTsignalling:a common theme in animal development. Genes and Develmmtent11, 3286–3305
15. Cartwright. P., MCLEAN. C., SHEPPARD, A., RIVETT. D., JONES. K. ANDDAIJON. S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripoteney by a Myc-dependent mechanism. Development132, 885–896
16. Catena, R., TIVERON. C., RONCHi, A. et al. (2004). Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. Journal of Biological Chemistry279, 41846–41857
17. Chambers. I., COLBY, D., ROBERTSON. M. et al. (2003). Functional expression cloning. of Nanog. a pluripotency sustaining factor in embryonicstem cells. Cell 113, 643–655
18. Ciccodicola, A., DONO, R., ORICI. S., SIMEONE. A., ZOLLO, M. and PERSICO, M (1989). Molecular characterization of agene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratmarcinomacells. EMBO Journal8, 1987–1991
19. Cobas. M., WILSON. A., ERNST.B.ETAT. (2004). Beta-eatenin is dispensable for haematopoiesis and lymphopoiesis. Journal of Etperinzeinal Medicine199, 221–229
20. Daheron, L., OPITZ, S.L., ZAEHKES, H. et al. (2004). L1F/STAT3 signalling fails to maintain self-renewal of human embryonic stem cells. Stem Cells22, 770–778
21. Ding, S., WU, T.Y., BRINKER. A. et al. (2003). Synthetic small molecules that control stemcell fate. Proceedings of the National Acadeno, of Sciences of the United States of America. 100, 7632–7637
22. Draper, J.S., MOORE, H.D., RUBAN, L.N., GOKHALE, P.J. and ANDREWS, P.W. (2004a). Culture and characterization of human embryonic stem cells. Stem Cells and Development13, 325–336
23. Draper, J.S., SMITH, K., GOKHALE, P. et al. (2004b). Recurrent gain of chromosomes I 7q and 12 in cultured human embryonic stem cells. Nature Biotechnology22, 53–54.
24. Dravid, G., YE, Z., HAMMOND, H. et al. (2005). Defining the role of WNT/(beta)-catenin signalling in the survival, proliferation and self-renewal of human embryonic stem cells. Stein Cells10, 1489–1501
25. Enver, T., SONEJI, S., JOSHI, C. et al. (2005). Cellular differentiation hierarchies in normal and culture adapted human embryonic stem cells. Human Molecular Genetics21, 3129–3140
26. Ernst, M., GEARING, D.P. and DUNN, A.R. (1994). Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130in embryonic stem cells. EMBO Journal13, 1574–1584
27. Evans, M.J. and KAUFMAN, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature292, 154–156
28. Fischer, M., GOLDSCHMTIT, J., PESCHEL, C. et al. (1997). I. A bioactive designer cytokine for human haematopoietic progenitor cell expansion. Nature Biotechnology15, 142–145
29. Frame, S. and COHEN, P. (2001).GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal359, 1–16
30. Fujikura, J., YAMATO, E., YONEMURA, S. et al. (2002). Differentiation of embryonic stem cells is induced by GATA factors. Genes and Development16, 784–789
31. Gertsenstein, M., LOBE, C. and NAGY, A. (2002). ES cell-mediated conditional transgenesis. Methods in Molecular Biology185, 285–307
32. Giesberts, A.N., DURAN, C., MORTON, I.N., PIGOTT, C., WHITE, S.J. and ANDREWS, P.W. (1999). The expressionand function of cadherin-mediated cell-to-cell adhesion in human embryonal carcinoma cells. Mechanisms of Development83, 115–125
33. Gu, P., GOODWIN, B., CHUNG, A.C. et al. (2005). Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression atthe epiblast stage of embryonic development. Molecular and Cellular Biology25, 3492–3505
34. Hay. D.C., SUTHERLAND, L., CLARK, J. and BURDON, T. (2004). Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers inhumanand mouse embryonic stem cells. Stem Cells22, 225–235
35. Heldin, C.H. and WESTERMARK, B. (1999). Mechanism of action and in vivo role of plateletderived growth factor. Physiological Reviews79, 1283–1316
36. Hovatta, O. and SKOTTMAN, H. (2005), Feeder-free derivation of human embryonic stem-cell lines. Lancet365, 1601–1603.
37. Humphrey. R.K., BEATTIE, G.M., LOPEZ. A.D. et al. (2004). Maintenance of pluripotency in human embryonic stemcells is STAT3 independent. Stem Cells22, 522–530
38. Hyslop. L., STOJKOVIC, M., ARMSTRONG, L. et al. (2005). Down regulation of NANOG induces differentiation of human embryonic stem cells to extra-embryonic lineages. Stem Cells. 23, 1035–1043
39. James, D., LEVINE, A.J., BESSER, D. and HEMMATI-BRIVANLOU, A. (2005). TGEbeta/activin/nodal signalling is necessary for the maintenance of pluripotency in human embryonic stern cells. Development132, 1273–1282
40. Jiirmanova, L., AFANASSIEFF, M., GOBERT-GOSSE, S., MARKOSSIAN, S. and SAVATIER, P. (2002). Differential contributions of ERK and P13-kinase to the regulation of cyclin Dl expression and to thecontrol of the GL/S transition in mouse embryonic stem cells. Oncogene21, 5515–5528
41. Kamachi, Y., UCHIKAWA, M. and KONDOH, H. (2000.) Pairing SOX off:with partners in the regulation of embryonic development. Trends in Genetics16, 182–187
42. Kandel, E.S., SKEEN, J., MAJEWSKI, N. et al. (2002). Activation of Akt/protein kinase B overcomes a G(2)/mcell cycle checkpoint induced by DNA damage. Molecular and Cellular Biology22, 7831–7841
43. Keller. G. (2005). Embryonic stem cell differentiation:emergence of a new era in biology and medicine. Genes and Development19, 1129–1155
44. Kleiman. M.F., RINDAPAA. M., GASPAR. C. et al. (2002). Apc modulates embryonic stemcell differentiation by controlling the dosage of beta-catenin signalling. Nature Genetics32, 594–605
45. Kim. S.J., CHEON, S.H., YOO, S.J. et al. (2005). Contribution of the PI3K/Akt/PKB signal pathway to maintenance of self-renewal in human embryonic stem cells. FEBS Letters579, 534–540
46. Klimanskaya. I., CHUNG. Y., M EISNER. L., JOHNSON.J., WEST.M.D. and LANZA. R. (2005). Human embryonic stem cells derived without feeder cells. Lancet365, 1636–164 I
47. Koutsourakes. M., LANGEVELD. A., PATIENT, R., BEDDINGTON. R. and GROSVELD. F. (1999).The transcription factor GATA6 is essential for early extra-embryonic development. Development126, 723–732
48. Kunath. T., STRUMPF, D. and ROSSANT. J. (2004). Early trophoblast determination and stem cell maintenance in the mouse- a review. Placenta25Suppl A. S32–38
49. Kuroda. T., TADA. M., KUBOTA. H. et al. (2005). Octainer and Sox elements are required for transcriptional cis regulation of Nanoggene expression. Molecular and Cellular Biology25, 2475–2485
50. Martin.G.R. (1981). Isolation of a pluripoteni cell line fromearly mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America78, 7634–7638
51. Matin, M.M., WALSH, J.R., GOKHALE, P.J. et al. (2004). Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stern cells and embryonic carcinoma cells. Stem Cells22, 659–668
52. Matsuda, T., NAKAMURA, T., NAKAO, K. et al. (1999).STAT3activation is sufficient to maintain an undifferentiated state of mouse embryonic siem cells. EMBO Journal18, 4261–4269
53. Minucci, S., BOTQUIN, V., YEOM. Y.I. et al. (1996). Retinoic acid-mediated down regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO Journal15, 888–899
54. Mitsui, K., TOKUZAWA, Y., ITOH, H. et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell113, 631–642
55. Morrisey, E.E., TANG, Z., SIGRIST, K. et al. (1998).GATA6 regulates FINF4 and is required for differentiation of-visceral endoderm in the mouse embryo. Genes and Development12, 3579–3590
56. Nishmito, M., FUKUSHIMA. A., OKUDA. A. and MURAMATSU. M. (1999). The gene for the embryonic stem cell coactivator UTEI carries a regulatory element which selectively interacts with acomplex composed of Oct-3/4 and Sox-2. Molecular and Cellular Biology19, 5453–5465
57. Niwa, H. (2001).Molecular mechanism to maintain stemcell renewal of ES cells. Cell Structure and Function26, 137–148
58. Niwa, H. (2004).Mechanismsof stem cell self-renewal. In:Handbook of stem cells. Volume I. Ed. R. Lanza, pp 45–52. London. UK:Academic Press
59. Niwa, H., BURDON, T., CHAMBERS. J. and SMITH. A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes and Development12, 2048–2060
60. Okuda. A., FUKUSWMA. A., NISHIMOTO. M. et al. (1998). UTF a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO Journal17, 2019–2032
61. Paling. N.R., WHEADON, H., BONE, H.K. and WELHAM, M.J. (2004). Regulation of embryonic stem cell self-renewal by phosphoi nosi tide 3-kinase-dependent signalling. Journal of Biological Chemistry279, 48063–48070
62. Pebay, A., WONG, R.C., PiTSON.S.M. et al. (2005). Essential roles of sphingosine-l-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stein Cells23, 1541–1548
63. Pera. M.F., ANDRADE.J., HOUSSAMI. S. et al. (2004). Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. Journal of Cell Science117, 1269–1280
64. Pinto, D. and CLEVERS, H. (2005). WNT control of stem cells and differentiation in the intestinal epithelium. Experimental Cell Research306, 357–363
65. Pinto, D., GREGORIEFF, A., BEGTHEL, H. and CLEVERS, H. (2003). Canonical WNT signals are essential for homeostasis of the intestinal epithelium. Genes and Development17, 1709–1713
66. Pyne, S. and PYNE, N.J. (2000). Sphingosine I-phosphate signalling in mammalian cells. Biochemical Journal349, 385–402
67. Reubinoff, B.E., PERA, M.F., FONG, C. Y., TROUNSON, A. and BONGSO.A. (2000).Embryonic stem cell lines from human blastocysts:somatic differentiation in varo. Nature Biotechnology18, 399–404
68. Reya, T. DUNCAN, A.W., AILLES, L. et al. (2003). A role for WNT signalling in self-renewal of haematopoietic stemcells. Nature423, 409–414
69. Rodda, D.J., CHEW, J.L., LIM, L.H. et al. (2005). Transcriptional regulation ofnanogby OCT4 and SOX2. Journal of Biological Chemistry280, 24731–24737
70. Rosner, M.H., VIGANO, M.A., OZAT0, K. et al. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature345, 686–692
71. Sato, N., MEIJER, L., SKALTSOUNIS, L., GREENGARD, P. and BRIVANLOU, A.H. (2004). Maintenance of pluripotency in human and mouse embryonicstem cells throughactivation of WNT signallingbya pharmacological GSK-3-specific inhibitor. Nature Medicine10, 55–63
72. Schuldiner, M., YANUKA, O., ITSKOVITZ-ELDOR. J., MELTON, D.A. and BENVENISTY, N. (2000). Effects of eight growth factorson the differentiation of cells derived from human embryonic stern cells. Proceedings of the National Academy of Sciences of the United States America97, 11307–11312
73. Shi. Y. and MASSAGUE, J. (2003). Mechanisms of TGF-beta signalling from cell membrane to the nucleus. Cell113, 685–700
74. Shufaro, Y. and REUBINOFF, B.E. (2004). Therapeutic applications of embryonic stem cells. Best Practice and Research. Clinical Obstetrics and Gynaecology18, 909–927
75. Smith, A.G. (2001). Embryo-derived stem cells:of mice and men. Annual Review of Cell and Developmental Biology17, 435–462
76. Smith, A.G., HEATH, J.K., DONALDSON, D.D. et al. (1988). Inhibition of pluripotential embryonicstern cell differentiation by purified polypeptides. Nature336, 688–690
77. Strelchenko. N., VERLINSKY, O., KUKHARENKO, V. and VERLINSKY. Y. (2004). Moruladerived human embryonic stem cells. Reproductive Biomedicine Online 9, 623–629
78. Sumi, T., FuJimoro, Y., NAKATSUJI, N. and SUEMORI. H. (2004). STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.Stem Cells 22, 861–871
79. Sun, H., LESCHE, R., LI, D.M. et al. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5, -trisphosphate and Akt/protein kinase B signalling path way. Proceedings of the National Academy of Sciences of the United States of America96, 6199–6204
80. Takuwa, Y. (2002). Subtype-specific differential regulation of Rho family G proteinsand cell migration by the Edg family sphingosine-l-phosphate receptors. Biochimica et Biophysica Act1582, 112–120
81. Tang, K., YANG, J., GAO, X. et al. (2002). WNT- I promotes neuronal differentiation and inhibits gliogenesis in P19cells. Biochemical and Biophysical Research Communications293, I67–173
82. Thomson, J.A., KALISHMAN, J., GOLDS, T.G. et al. (1995). Isolation ofa primate embryonic stem cell line. Proceedings of the National Academy of Sciences of the United States of America92, 7844–7848
83. Thomson, J.A., KALISHMAN, J., GOLOS, T.G., DURNING, M., HARRIS, C.P. and HEARN, J.P. (1996). Pluripotent celllines derived from common marmoset(Callithrixfnechns) blastocysts. Biology of Reproduction55, 254–259
84. Thomson, J.A., ITSKOVITZ-ELDOR, J., SHAPIRO, S.S. et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science282, 1145–1147
85. TommA. M., NISHiMOTo. M., MIYAGI, S. ETAL. (2002). Identification of Sox-2 regulatory region which is under the control of Oct-314-Sox-2complex. NucleicAcids Research30, 3202–3113
86. Valuer. L., REYNOLDS, D. and PEDERSEN, R.A. (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Developmental Biology275, 403–421
87. Valuer, L., ALEXANDER, M. and PEDERSEN, R.A. (2005). Activin/Nodaland FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. Journal of Cell Science118, 4495–4509
88. VAN DE WETERING, M., SANCHO, E., VERWEU, C. et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt pronnitor phenotype on colorectal cancercells. Cell111, 241–250
89. Viswanathan, S., BENATAR, T., ROSE-JOHN, S., LAUFFENBURGER, D.A. and ZANDSTRA, P.W. (2002). Ligand/receptor signalling threshold (LIST) model accounts for gp1 30-mediated embryonic stem cell self-renewal responses to LIF and H-IL-6. Stem Cells20, 119–138
90. Vivanco, I. and SAWYERS, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Reviews Cancer2, 489–501
91. Walsh, J. and ANDREWS, P.W. (2003). Expression ofWNT and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stein cell. APMLS111, 197–210:discussion 210–211
92. Wang, G., ZHANG, H., ZHAO, Y. et al. (2005). Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochemical and Biophysical Research Communications330, 934–942
93. Wei, C.L. MIURA, T.,. ROBSON, P. et al. (2005).Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells23, 166–185
94. Williams, R.L., HILTON, D.J., PEASE, S. et al. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature336, 684–687
95. Xu, C., INOKUMA, M.S., DENHAM, J. et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology19, 971–974
96. Xu, C., ROSLER, E., JIANG, J. et al. (2005a). Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem cells23, 315–323
97. Xu, R.H., CHEN, X., LI, D.S. et al. (2002). BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nature Biotechnology20, 1261–1264
98. Xu, R.H., PECK, R.M., LI, D.S., PENG, X., LUDWIG, T. and THOMSON, J.A. (2005b). Basic FGF and suppression of BMP signalling sustain undifferentiated proliferation of human ES cells. Nature Methods2, 185–190
99. Yeo, C. and WHITMAN, M. (2001). Nodal signals to Smads through Cripto-dependent and Criptoinde pendent mechanisms. Molecular Cell7, 949–957
100. Yeom. Y.I., PUHRMANN, G., OVITT. C.E. et al. (1996). Germline regulatory element of Oct-4 specific for the to tipotent cycle of embryonal cells. Development122, 881–894
101. Ying. Q.L., NiCHOLs. J., CHAMBERS. I. and SMITH, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell115, 281–292
102. Yoshida, K., CHAMBERS. I., NICHOLS. J. et al. (1994). Maintenance of the pluripotential phenotype of embryonicstein cells through direct activation of gpI30 signalling pathways. Mechanisms of Development 45, 163–171
103. Yuan, H., CORBI, N., BAsmoo, C.AND DAILEY, L. (1995). Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes and Development9, 2635–2645
104. Zandstra, P.W., LE. H.V., DALEY, G.Q., GRIFFITH, L.G. and LAUFFENBURGER, D.A. (2000). Leukaemia inhibitory factor (LIF) concentration modulates embryonicstem cell self-renewal and differentiation independently of proliferation. Biotechnology and Bioengineering69, 607–617